[1]
O. Haliloglu, M. Korkmaz, O. Polat Korkmaz, S. Sahin, E. Durcan, and Z. Osar Siva, “Retrospective evaluation of insulin degludec/insulin aspart co-formulation therapy in patients with type 2 Diabetes Mellitus: A single-center experience ”, annalsmedres, vol. 27, no. 7, pp. 1961–1965, May 2021.